📰 Alpha Da News
Page 7 - Alpha Da News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Alpha Da. Real-time updates on events, politics, business and more.
October 21, 2022
- Medicines and Healthcare products Regulatory Agency of the United Kingdom approves clinical trial in squamous cell carcinoma of the vulva at Addenbrookes...
September 2, 2022
JERUSALEM, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS) ("Alpha Tau"), the developer of the innovative alpha-radiation cancer...
September 1, 2022
JERUSALEM, Sept. 01, 2022 -- Alpha Tau Medical Ltd. , the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that Peter Melnyk, a member of its board of... | September 1, 2022
August 30, 2022
30.08.2022 - JERUSALEM, Aug. 30, 2022 (GLOBE NEWSWIRE) - Alpha Tau Medical Ltd. (Nasdaq: DRTS) (Alpha Tau), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT, today announced the Company will participate in person at three upcoming ...
July 6, 2022
(2022-07-05 | NDAQ:DRTS) Alpha Tau Hosting Key Opinion Leader Meeting on Alpha DaRT Clinical Trials
July 5, 2022
JERUSALEM, July 05, 2022 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS) ("Alpha Tau" or the “Company”), the developer of the innovative...
June 29, 2022
Patient, 60, is given alpha-radiation to target the tumor without harming healthy tissue in ‘historical’ procedure
June 22, 2022
/PRNewswire/ -- Alpha Tau Medical Ltd. (Nasdaq: DRTS) ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced...
June 16, 2022
/PRNewswire/ -- Alpha Tau Medical Ltd. (Nasdaq: DRTS) ("Alpha Tau" or the "Company"), the developer of the innovative alpha-radiation cancer therapy Alpha...
June 8, 2022
/PRNewswire/ -- Alpha Tau Medical Ltd. (Nasdaq: DRTS and DRTSW), ("Alpha Tau" or the "Company"), the developer of the innovative alpha-radiation cancer therapy...